Single-cell analysis reveals inflammatory interactions driving macular degeneration
Manik Kuchroo,Marcello DiStasio,Eric Song,Eda Calapkulu,Le Zhang,Maryam Ige,Amar H. Sheth,Abdelilah Majdoubi,Madhvi Menon,Alexander Tong,Abhinav Godavarthi,Yu Xing,Scott Gigante,Holly Steach,Jessie Huang,Guillaume Huguet,Janhavi Narain,Kisung You,George Mourgkos,Rahul M. Dhodapkar,Matthew J. Hirn,Bastian Rieck,Guy Wolf,Smita Krishnaswamy,Brian P. Hafler
DOI: https://doi.org/10.1038/s41467-023-37025-7
IF: 16.6
2023-05-05
Nature Communications
Abstract:Abstract Due to commonalities in pathophysiology, age-related macular degeneration (AMD) represents a uniquely accessible model to investigate therapies for neurodegenerative diseases, leading us to examine whether pathways of disease progression are shared across neurodegenerative conditions. Here we use single-nucleus RNA sequencing to profile lesions from 11 postmortem human retinas with age-related macular degeneration and 6 control retinas with no history of retinal disease. We create a machine-learning pipeline based on recent advances in data geometry and topology and identify activated glial populations enriched in the early phase of disease. Examining single-cell data from Alzheimer’s disease and progressive multiple sclerosis with our pipeline, we find a similar glial activation profile enriched in the early phase of these neurodegenerative diseases. In late-stage age-related macular degeneration, we identify a microglia-to-astrocyte signaling axis mediated by interleukin-1 β which drives angiogenesis characteristic of disease pathogenesis. We validated this mechanism using in vitro and in vivo assays in mouse, identifying a possible new therapeutic target for AMD and possibly other neurodegenerative conditions. Thus, due to shared glial states, the retina provides a potential system for investigating therapeutic approaches in neurodegenerative diseases.
multidisciplinary sciences